The Use of Intravenous Immunoglobulin (IVIG) during Severe Neurotoxicity Among the Recipients of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

被引：2

作者：

Mokhtari, Sepideh ^{[1
]}

Asquith, Justin M. ^{[2
]}

Bachmeier, Christina A. ^{[3
]}

Jain, Michael D. ^{[3
]}

Forsyth, Peter ^{[1
]}

Locke, Frederick L. ^{[3
]}

Kim, Youngchul ^{[1
]}

Lazaryan, Aleksandr ^{[3
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[2] Univ S Florida, Moffitt Canc Ctr, Tampa, FL 33620 USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-122343

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5627

引用

页数：3

共 50 条

[41] Treatment Outcomes in Patients with R/R CNSL in the Era of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Yang, Fan
Liu, Rui
Fu, Zhonghua
Guo, Yuelu
Ma, Lixia
Shi, Hui
Deng, Biping
Ke, Xiaoyan
Hu, Kai
BLOOD, 2024, 144 : 3079 - 3080
[42] Conversion of cellular kinetic data for chimeric antigen receptor T-cell therapy (CAR-T) into interpretable units.
Chaudhury, Anwesha
Stein, Andrew
Grupp, Stephan
Levine, John
Pulsipher, Michael
Myers, G. Doug
Waldron, Edward
Zhu, Xu
McBlane, Fraser
Awasthi, Rakesh
Waller, Edmund K.
CANCER RESEARCH, 2021, 81 (13)
[43] Intrathecal Chemotherapy As Treatment for Chimeric Antigen Receptor T Cell (CAR T) Therapy Associated Neurotoxicity
Solh, Melhem M.
Bashey, Asad
Morris, Lawrence
Bachier-Rodriguez, Lizamarie
Holland, H. Kent
Zhang, Xu
Jackson, Katelin C.
Solomon, Scott R.
BLOOD, 2023, 142
[44] Intrathecal chemotherapy as treatment for chimeric antigen receptor T cell (CAR T) therapy associated neurotoxicity
Bashey, Saffiya Z.
Solomon, Scott R.
Zhang, Xu
Morris, Lawrence E.
Holland, H. Kent
Bachier, Lizamarie
Patel, Krishi
Solh, Melhem M.
BONE MARROW TRANSPLANTATION, 2024, 59 (12) : 1783 - 1785
[45] Worsening Financial Toxicity Among Patients Receiving Chimeric Antigen Receptor t-Cell (CAR-T) Therapy: A Mixed Methods Longitudinal Study
Cusatis, Rachel
Tan, Irena
Piehowski, Claire
Akinola, Idayat
Crawford, Emma
Craig, Juliana
Thiengmany, Aline
Frank, Matthew J.
Miklos, David B.
Shah, Nirav N.
D'Souza, Anita
Knight, Jennifer M.
Muffly, Lori
Flynn, Kathryn E.
Sidana, Surbhi
BLOOD, 2021, 138
[46] Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy
Shannon P. Fortin Ensign
Charles Gaulin
Maya Hrachova
Michael Ruff
Ehab Harahsheh
Kevin Vicenti
Januario Castro
Javier Munoz
Allison Rosenthal
Maciej M. Mrugala
Current Treatment Options in Oncology, 2022, 23 : 1845 - 1860
[47] Clinical Predictors of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy
Rubin, Daniel B.
Al Jarrah, Ali
Li, Karen
LaRose, Sarah
Monk, Andrew D.
Ali, Ali Basil
Spendley, Lauren N.
Nikiforow, Sarah
Jacobson, Caron
Vaitkevicius, Henrikas
JAMA NEUROLOGY, 2020, 77 (12) : 1536 - 1542
[48] Risk Factors With Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy
Liu, Fujun
Tang, Xin
Zhou, Liangxue
JAMA NEUROLOGY, 2021, 78 (06) : 763 - 764
[49] Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy
Fortin Ensign, Shannon P.
Gaulin, Charles
Hrachova, Maya
Ruff, Michael
Harahsheh, Ehab
Vicenti, Kevin
Castro, Januario
Munoz, Javier
Rosenthal, Allison
Mrugala, Maciej M.
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (12) : 1845 - 1860
[50] Polatuzumab Vedotin Use before Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Aggressive Lymphoma: A US Single Center Experience
Khurana, Arushi
Bansal, Radhika
Hathcock, Matthew
Nedved, Adrienne
Wang, Yucai
Paludo, Jonas
Villasboas, Jose C.
Bennani, N. Nora
Johnston, Patrick B.
Ansell, Stephen M.
Lin, Yi
BLOOD, 2021, 138 : 3842 - +

← 1 2 3 4 5 →